| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/27/2023 | 33.33% | Credit Suisse | $22 → $25 | Maintains | Outperform |
| 07/12/2023 | 1.33% | Benchmark | → $19 | Reiterates | Buy → Buy |
| 05/08/2023 | 28% | JP Morgan | → $24 | Initiates Coverage On | → Overweight |
| 02/23/2023 | 17.33% | Credit Suisse | → $22 | Reiterates | → Outperform |
| 02/23/2023 | 6.67% | BMO Capital | $15 → $20 | Maintains | Outperform |
| 02/23/2023 | -4% | Deutsche Bank | $17 → $18 | Maintains | Buy |
| 01/24/2023 | -9.33% | Deutsche Bank | $12.5 → $17 | Maintains | Buy |
| 12/01/2022 | 17.33% | Credit Suisse | $24 → $22 | Maintains | Outperform |
| 10/13/2022 | -20% | Goldman Sachs | $22 → $15 | Maintains | Buy |
| 07/29/2022 | 17.33% | Deutsche Bank | $25 → $22 | Maintains | Buy |
| 02/24/2022 | 38.67% | Benchmark | $24 → $26 | Maintains | Buy |
| 12/10/2021 | 12% | JP Morgan | $22 → $21 | Downgrades | Overweight → Neutral |
| 11/17/2021 | 28% | Wolfe Research | → $24 | Initiates Coverage On | → Outperform |
| 10/28/2021 | 28% | Credit Suisse | $26 → $24 | Maintains | Outperform |
| 09/10/2021 | 33.33% | Goldman Sachs | → $25 | Initiates Coverage On | → Buy |
| 04/29/2021 | 22.67% | Credit Suisse | $19 → $23 | Maintains | Outperform |
| 04/23/2021 | -4% | JP Morgan | → $18 | Initiates Coverage On | → Overweight |
| 03/22/2021 | 12% | Northland Capital Markets | $14 → $21 | Upgrades | Market Perform → Outperform |
| 02/08/2021 | -30.67% | Northland Capital Markets | → $13 | Downgrades | Outperform → Market Perform |
| 12/17/2020 | -4% | BMO Capital | → $18 | Upgrades | Market Perform → Outperform |
| 04/30/2020 | -52% | BMO Capital | $6 → $9 | Maintains | Market Perform |
| 04/27/2020 | 1.33% | Credit Suisse | $25 → $19 | Maintains | Outperform |
| 01/16/2020 | -9.33% | Benchmark | → $17 | Initiates Coverage On | → Buy |
| 01/13/2020 | 1.33% | Northland Capital Markets | → $19 | Initiates Coverage On | → Outperform |
| 10/15/2019 | 22.67% | Credit Suisse | $20 → $23 | Maintains | Outperform |
| 10/30/2018 | -35.47% | Societe Generale | → $12.1 | Upgrades | Hold → Buy |
| 10/26/2018 | -41.33% | BMO Capital | $14 → $11 | Maintains | Market Perform |
| 08/01/2018 | -14.67% | Morgan Stanley | $15 → $16 | Maintains | Overweight |
What is the target price for Constellium (CSTM)?
The latest price target for Constellium (NYSE: CSTM) was reported by Credit Suisse on July 27, 2023. The analyst firm set a price target for $25.00 expecting CSTM to rise to within 12 months (a possible 33.33% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Constellium (CSTM)?
The latest analyst rating for Constellium (NYSE: CSTM) was provided by Credit Suisse, and Constellium maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Constellium (CSTM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Constellium, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Constellium was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.
Is the Analyst Rating Constellium (CSTM) correct?
While ratings are subjective and will change, the latest Constellium (CSTM) rating was a maintained with a price target of $22.00 to $25.00. The current price Constellium (CSTM) is trading at is $18.75, which is out of the analyst's predicted range.